focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,182.00
Bid: 1,186.00
Ask: 1,188.00
Change: 21.00 (1.81%)
Spread: 2.00 (0.169%)
Open: 1,181.00
High: 1,188.00
Low: 1,168.00
Prev. Close: 1,161.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Apr 2024 16:01

RNS Number : 2067J
Hiscox Ltd
03 April 2024
 

 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMR")

 

 

Hamilton, Bermuda - Further to the Company's announcement on 17 May 2022, the third tranche of the buy-out award made to Paul Cooper, the Company's Chief Financial Officer, under the Company's Performance Share Plan (the "Plan") comprising 42,945 ordinary shares of 6.5p each ("Shares"), vested on 1 April 2024 (the "Award").

 

In accordance with the terms of the Plan, Mr Cooper also received an additional 1,484 Shares equivalent to the value of dividends paid by the Company between the date of grant and the date of vesting in respect of Shares under the Award which vested.

 

On 2 April 2024, Mr Cooper sold 20,955 Shares at a price of £12.43 per Share to cover associated tax liabilities.

 

The notifications set out below are made in accordance with the UK version of the EU Market Abuse Regulation (2014/596/EU) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

Marc Wetherhill

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Cooper

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - Chief Financial Officer

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Hiscox Ltd

b)

 

LEI

 

 

5493007JXOLJ0QCY2D70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

 

b)

 

Nature of the transaction

 

 

Receipt of shares in satisfaction of the buy-out award granted under the Company's Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

nil

44,429

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

Aggregated Volume

 

Aggregated Price

44,429

nil

 

 

e)

Date of the transaction

2024-04-01

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

 

b)

 

Nature of the transaction

 

 

Sale of shares to cover tax

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

GBP12.43

20,955

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

Aggregated Volume

 

Aggregated Price

Total Price

20,955

GBP12.43

GBP260,470.65

 

 

e)

Date of the transaction

2024-04-02

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE, XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDSDDGDGSX
Date   Source Headline
3rd Apr 20234:08 pmRNSTotal Voting Rights
24th Mar 20231:30 pmRNSNotice of 2023 AGM & 2022 Annual Report & Accounts
22nd Mar 202311:03 amRNSDirector/PDMR Shareholding
9th Mar 20233:46 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSSyndicates 33 and 6104 – results and estimates
8th Mar 20237:01 amRNSFull Year Results
8th Mar 20237:00 amRNSRobert Childs to retire from the Board as Chairman
2nd Mar 20237:00 amRNSTotal Voting Rights to 28 February 2023
1st Feb 20234:55 pmRNSTotal Voting Rights
16th Jan 20233:13 pmRNSDirector/PDMR Shareholding
13th Jan 20236:12 pmRNSAveva Group
7th Dec 20222:21 pmRNSDirector/PDMR Shareholding
1st Dec 202212:45 pmRNSTotal Voting Rights
28th Nov 20227:00 amRNSDirector PDMR Shareholding
14th Nov 202211:08 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20227:00 amRNSQ3 2022 Trading Statement
1st Nov 20224:19 pmRNSTotal Voting Rights
3rd Oct 20225:06 pmRNSTotal Voting Rights
26th Sep 20224:09 pmRNSDirector/PDMR Shareholding
22nd Sep 202211:00 amRNSDirector/PDMR Shareholding
15th Sep 20222:13 pmRNSApplication to be Admitted to the Official List
7th Sep 202212:04 pmRNSAnnouncement of the Scrip Reference Share price
6th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:04 pmRNSTotal Voting Rights
12th Aug 20221:38 pmRNSDirector PDMR Shareholding
10th Aug 202212:29 pmRNSSyndicate Results
9th Aug 202211:05 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSInterim Report
6th Jul 202211:35 amRNSTotal Voting Rights
15th Jun 20222:05 pmRNSDirector/PDMR Shareholding
9th Jun 20221:09 pmRNSApplication to be Admitted to the Official List
31st May 20223:29 pmRNSAnnouncement of Scrip Reference Share Price
17th May 20225:30 pmRNSDirector/PDMR Shareholding
13th May 20223:30 pmRNSAppointment of Paul Cooper
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.